2011 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 5
As coordinator: 2
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0.67*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 11.941.121 | 11.691.903 | 3.906.019 | 2 | 2 | |
2011 | 0 | 11.997.959 | 130.152 | 1 |
Total number of partners: 79
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 79
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-10-01 | EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma | EEC | participant | 5.697.831 | 20 |
2013-10-01 | A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer | GANNET53 | participant | 5.994.072 | 18 |
2013-09-01 | First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept | HERMIONE-2MAN | coordinator | 5.962.231 | 4 |
2013-09-01 | Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers | TUMADOR | coordinator | 5.978.890 | 8 |
2011-01-01 | EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS | ENCCA | participant | 11.997.959 | 34 |